Coherus Oncology, Inc.
CHRS
$1.42
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -38.33M | -37.64M | -35.53M | -- | -56.57M |
| Total Depreciation and Amortization | 881.00K | 896.00K | 966.00K | -- | 1.05M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.24M | 691.00K | -2.39M | -- | 18.84M |
| Change in Net Operating Assets | -23.68M | 16.34M | -9.39M | -- | 10.86M |
| Cash from Operations | -57.89M | -19.72M | -46.34M | -- | -25.83M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 30.66M | -2.84M | -67.23M | -- | -17.49M |
| Cash from Investing | 30.66M | -2.84M | -67.23M | -- | -17.49M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | -- | -- |
| Issuance of Common Stock | 53.65M | 8.06M | 0.00 | -- | -- |
| Repurchase of Common Stock | -112.00K | 0.00 | -3.00K | -- | -264.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 52.00K | 22.00K | 5.00K | -- | -- |
| Cash from Financing | 53.59M | 8.08M | 2.00K | -- | -264.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.36M | -14.47M | -113.56M | -- | -43.58M |